Add this topic to your myFT Digest for news straight to your inbox
Cross-border funding is far below its 2007 peak, but with uncertain effects
The new head of the Swiss drugs group is adopting a different leadership style
Swiss firm Herzog & de Meuron team up with Anglo-Swiss group
Pharma groups face challenges merger would not address
The art world summer break is a chance to take stock
Maurizio Cattelan announced his retirement from making art. Now he has a new show
Sensible proposal from the BIS, but there are drawbacks
This show hopes to demonstrate that Manhattan still matters in the art world
In keeping with the massive scale of the project, brand stands have also had a makeover, writes Jessica Diamond
A study of the central bankers entrusted with saving the global economy praises their boldness but skates over their weak spots
Other countries should follow Germany’s lead
Basel proposals will hit companies looking to raise funds abroad
International Edition